The Credit Suisse Liquid Alternative Beta (LAB) Index was up 1.10 per cent in January, according to Dr Jordan Drachman, head of alternative beta strategies at Credit Suisse.

The merger arbitrage strategy was the strongest performer for the month, finishing up 2.31 per cent.

The index aims to reflect the performance of the overall hedge fund industry.